V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 290007189 | 290005515 | 1.7 | 0 | Neo-adjuvant (N) | 2017-08-15 | 2017-10-15 | IBRUTINIB | N | N | 290022527 | CISPLATIN |
| 290007190 | 290005517 | 1.72 | 63.4 | Palliative (P) | 2016-11-24 | 2016-11-28 | LANREOTIDE | 01 | N | 290022530 | MCX |
| 290007191 | 290005518 | 1.78 | 56 | Palliative (P) | 2016-08-29 | 2016-10-12 | Rituximab | N | N | 290022536 | CAPECITABINE + OXALIPLATIN |
| 290007192 | 290005518 | null | null | Curative (C) | 2014-07-17 | 2014-07-17 | Sunitinib | null | null | 290022536 | INTERAACT TRIAL |
| 290007193 | 290005518 | 1.69 | 111 | Disease modification (D) | 2013-05-26 | 2013-06-09 | CETUXIMAB + RT | 02 | N | 290022536 | DA |
| 290007194 | 290005518 | 1.6 | 103.15 | Curative (C) | null | 2015-05-26 | Bortezomib +/- Dexamethasone | null | N | 290022536 | CISPLATIN + RT |
| 290007195 | 290005519 | 1.88 | 64 | null | 2018-05-27 | 2018-06-17 | Capecitabine + Cisplatin | N | N | 290022559 | TRIAL |
| 290007196 | 290005521 | null | 58.4 | null | 2017-11-09 | 2017-11-09 | Paclitaxel 80mg/m2 day 1 8 15 | N | N | 290022560 | CETUXIMAB + RT |
| 290007197 | 290005523 | null | null | Palliative (P) | 2013-11-12 | 2013-11-12 | CHOP | 02 | null | 290022562 | CARBOPLATIN + ETOPOSIDE |
| 290007198 | 290005524 | 1.66 | null | Palliative (P) | 2015-05-10 | 2015-05-29 | Docetaxel | null | Y | 290022565 | TRIAL |
| 290007199 | 290005526 | 1.73 | 61.8 | Palliative (P) | 2019-04-11 | 2019-07-04 | Hydroxycarbamide | 02 | N | 290022568 | PANITUMUMAB |
| 290007200 | 290005527 | 0 | 48.1 | Curative (C) | 2018-07-23 | 2018-07-23 | LANREOTIDE | N | N | 290022569 | CISPLATIN |
| 290007201 | 290007339 | 1.57 | null | Palliative (P) | 2015-02-06 | 2015-02-06 | Carboplatin + Etoposide IV 3 day | null | N | 290022572 | TRASTUZUMAB |
| 290007202 | 290005529 | 1.6 | 64 | null | 2015-05-09 | 2015-05-11 | Carboplatin+Fluorouracil 4 or 5 day | Y | N | 290022576 | CAPECITABINE + OXALIPLATIN |
| 290007203 | 290005530 | 1.82 | 77 | null | 2013-08-12 | 2014-10-11 | Rituximab | 2 | N | 290022587 | CAPECITABINE + RT |
| 290007204 | 290005530 | 1.73 | 123.7 | Neo-adjuvant (N) | 2017-12-13 | 2017-12-13 | CABOZANTINIB | N | N | 290022587 | EC |
| 290007205 | 290008049 | 1.77 | null | Curative (C) | 2014-07-11 | 2014-07-22 | Capecitabine + Oxaliplatin 21day | 99 | N | 290022601 | FLUOROURACIL + MITOMYCIN |
| 290007206 | 290008049 | 1.77 | 48.2 | Curative (C) | 2018-03-12 | 2018-03-15 | Cetuximab +Cisplatin + FU (Cycle 1) | 02 | null | 290022601 | CARBOPLATIN |
| 290007207 | 290005533 | null | 44.35 | Palliative (P) | 2015-06-22 | 2015-07-06 | CARBOPLATIN + Cetuximab + FLUOROURACIL | null | N | 290022604 | CETUXIMAB |
| 290007208 | 290005534 | 1.74 | 65 | Curative (C) | 2014-05-17 | 2014-05-17 | CAPECITABINE + TEMOZOLOMIDE | 2 | N | 290022607 | CISPLATIN + FLUOROURACIL + RT |
| 290007209 | 290005534 | null | 58.4 | Disease modification (D) | null | 2014-07-17 | Y-90 | N | N | 290022607 | LANREOTIDE |
| 290007210 | 290007345 | 1.63 | 91.4 | Palliative (P) | 2015-11-23 | 2015-12-06 | Capecitabine | 2 | N | 290022612 | Y-90 |
| 290007211 | 290008314 | null | 99.6 | Palliative (P) | 2015-05-09 | 2015-06-03 | Sunitinib | N | N | 290022612 | PEMBROLIZUMAB |
| 290007212 | 290005538 | 1.52 | 88.9 | Palliative (P) | 2014-04-21 | 2014-04-29 | LANREOTIDE | 02 | N | 290022620 | TRABECTEDIN |
| 290007213 | 290005538 | 1.62 | 63.5 | Disease modification (D) | 2016-06-10 | 2016-07-03 | CETUXIMAB + RT | N | N | 290022620 | DA |
| 290007214 | 290005538 | null | 68.8 | Adjuvant (A) | 2015-04-25 | 2015-04-25 | Capecitabine | 2 | N | 290022620 | CAPECITABINE + OXALIPLATIN |
| 290007215 | 290005538 | 1.74 | 52.55 | Palliative (P) | 2014-02-20 | 2014-03-04 | Carboplatin AUC 6 - 10 | 02 | N | 290022620 | SUNITINIB |
| 290007216 | 290005539 | 1.6 | null | Palliative (P) | 2013-11-30 | 2014-01-08 | Capecitabine (21days) + Carboplatin | N | N | 290022640 | TRIAL |
| 290007217 | 290005539 | 1.67 | 0 | Palliative (P) | 2015-12-24 | 2015-12-24 | Cisplatin | 2 | N | 290022640 | CETUXIMAB + CISPLATIN + FLUOROURACIL |
| 290007218 | 290005540 | 1.74 | 74.7 | Palliative (P) | 2016-08-28 | 2017-01-23 | Irinotecan 14day | N | N | 290022645 | ERLOTINIB |
| 290007219 | 290005541 | 1.5 | 77.6 | Palliative (P) | null | 2017-07-20 | LANREOTIDE | N | N | 290022648 | CETUXIMAB |
| 290007220 | 290005546 | 1.52 | 66.5 | Palliative (P) | 2017-02-11 | 2017-02-23 | Everolimus 10mg | null | N | 290022654 | CETUXIMAB |
| 290007221 | 290005547 | 0 | 86 | Palliative (P) | 2016-05-26 | 2016-07-26 | Trastuzumab + VINORELBINE | N | N | 290022655 | BORTEZOMIB |
| 290007222 | 290005547 | 1.73 | 91 | Palliative (P) | 2013-05-11 | 2014-01-14 | CARBOPLATIN + PACLITAXEL | 2 | N | 290022655 | CAPECITABINE + IRINOTECAN |
| 290007223 | 290007352 | 1.46 | null | Palliative (P) | 2016-10-03 | 2016-10-06 | FLUOROURACIL + MITOMYCIN | N | N | 290022662 | SUNITINIB |
| 290007224 | 290005549 | 1.87 | 58.8 | Adjuvant (A) | 2014-01-07 | 2014-04-11 | CYTARABINE + DAUNORUBICIN | N | N | 290022662 | CAPECITABINE + OXALIPLATIN |
| 290007225 | 290005550 | 1.88 | 92.5 | Neo-adjuvant (N) | 2017-04-10 | 2017-09-02 | LANREOTIDE | 02 | N | 290022673 | FLUOROURACIL + MITOMYCIN |
| 290007226 | 290005551 | 1.52 | null | Curative (C) | 2016-11-08 | 2016-11-14 | EOX | 02 | N | 290022674 | CARBOPLATIN |
| 290007227 | 290007354 | 1.74 | 63.6 | Curative (C) | 2017-11-08 | 2017-11-08 | Cisplatin 100 + RT(H&N) 1 day | 02 | N | 290022684 | CISPLATIN + RT |
| 290007228 | 290005552 | 1.68 | 74.2 | Adjuvant (A) | null | 2019-07-26 | MCX | N | Y | 290022684 | CAPECITABINE + OXALIPLATIN |
| 290007229 | 290005552 | 1.8 | null | Palliative (P) | 2017-09-05 | 2018-01-10 | Sunitinib | 2 | N | 290022684 | SUNITINIB |
| 290007230 | 290005552 | 1.61 | 52.7 | Adjuvant (A) | 2018-12-08 | 2018-12-22 | Rituximab | 2 | null | 290022684 | CAPECITABINE |
| 290007232 | 290005554 | 1.64 | 88 | Curative (C) | null | 2018-10-06 | CAPECITABINE + OXALIPLATIN | N | Y | 290022695 | CAP + RT |
| 290007233 | 290005555 | 1.7 | 75.4 | Adjuvant (A) | 2014-12-12 | 2015-05-11 | Trial Unspecified | N | N | 290022699 | CAPECITABINE |
| 290007234 | 290005556 | 1.6 | 54.6 | null | 2015-10-07 | 2016-08-11 | Capecitabine | 02 | Y | 290022708 | FLUOROURACIL + MITOMYCIN |
| 290007236 | 290007356 | 1.52 | 101.9 | Curative (C) | 2014-08-06 | 2014-09-01 | CETUXIMAB + RT | 01 | Y | 290022722 | CISPLATIN + RT |
| 290007237 | 290007357 | 1.63 | 52.5 | Not known (9) | 2018-04-24 | 2018-04-27 | CAPECITABINE + RT | 02 | null | 290022734 | BORTEZOMIB + THALIDOMIDE |
| 290007238 | 290005559 | 1.71 | null | null | null | 2013-03-17 | Capecitabine 35days + RT | N | N | 290022737 | CETUXIMAB + RT |
| 290007239 | 290005559 | 1.81 | 77.7 | Curative (C) | 2013-06-05 | 2013-06-08 | LANREOTIDE | 02 | Y | 290022737 | TRIAL |
| 290007240 | 290005559 | 1.6 | 76.5 | Palliative (P) | 2014-09-11 | 2015-03-05 | CETUXIMAB | 02 | N | 290022737 | PANITUMUMAB |